Assessment tools for systemic lupus erythematosus
© 2023. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature..
A systematic assessment is critical for taking advantage of the current options for optimizing systemic lupus erythematosus (SLE) management. Without regular SLE activity measurements, treat to target and remission are empty words, and the EULAR recommendations therefore insist on these assessments. They rely on activity scores, such as SLEDAI, ECLAM and BILAG or more recently, EasyBILAG and SLE-DAS. Assessment is completed by organ-specific measurement methods and the evaluation of damage. In the study setting the classification criteria and combined endpoints for clinical testing are crucial, as is measurement of the quality of life. This review article provides an overview of the current state of SLE assessments.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:82 |
---|---|
Enthalten in: |
Zeitschrift fur Rheumatologie - 82(2023), 5 vom: 15. Juni, Seite 361-367 |
Sprache: |
Deutsch |
---|
Weiterer Titel: |
Assessment-Tools für den systemischen Lupus erythematodes |
---|
Beteiligte Personen: |
Aringer, Martin [VerfasserIn] |
---|
Links: |
---|
Themen: |
Damage |
---|
Anmerkungen: |
Date Completed 15.06.2023 Date Revised 15.06.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1007/s00393-023-01359-w |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM356916499 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM356916499 | ||
003 | DE-627 | ||
005 | 20231226071455.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||ger c | ||
024 | 7 | |a 10.1007/s00393-023-01359-w |2 doi | |
028 | 5 | 2 | |a pubmed24n1189.xml |
035 | |a (DE-627)NLM356916499 | ||
035 | |a (NLM)37188996 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a ger | ||
100 | 1 | |a Aringer, Martin |e verfasserin |4 aut | |
245 | 1 | 0 | |a Assessment tools for systemic lupus erythematosus |
246 | 3 | 3 | |a Assessment-Tools für den systemischen Lupus erythematodes |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 15.06.2023 | ||
500 | |a Date Revised 15.06.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2023. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature. | ||
520 | |a A systematic assessment is critical for taking advantage of the current options for optimizing systemic lupus erythematosus (SLE) management. Without regular SLE activity measurements, treat to target and remission are empty words, and the EULAR recommendations therefore insist on these assessments. They rely on activity scores, such as SLEDAI, ECLAM and BILAG or more recently, EasyBILAG and SLE-DAS. Assessment is completed by organ-specific measurement methods and the evaluation of damage. In the study setting the classification criteria and combined endpoints for clinical testing are crucial, as is measurement of the quality of life. This review article provides an overview of the current state of SLE assessments | ||
650 | 4 | |a English Abstract | |
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a Damage | |
650 | 4 | |a Disease activity | |
650 | 4 | |a Fatigue | |
650 | 4 | |a Low disease activity | |
650 | 4 | |a Remission | |
700 | 1 | |a Leuchten, Nicolai |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Zeitschrift fur Rheumatologie |d 1974 |g 82(2023), 5 vom: 15. Juni, Seite 361-367 |w (DE-627)NLM000024287 |x 1435-1250 |7 nnns |
773 | 1 | 8 | |g volume:82 |g year:2023 |g number:5 |g day:15 |g month:06 |g pages:361-367 |
856 | 4 | 0 | |u http://dx.doi.org/10.1007/s00393-023-01359-w |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 82 |j 2023 |e 5 |b 15 |c 06 |h 361-367 |